However, in breast cancer, aromatase levels are increased by the activation of the II and I.3 promoters in malignant epithelial cells and adjacent fibroblasts, and by the I.7 promoter in adjacent endothelial cells [46,47]. This evidence concerns the gene CYP19A1 and breast carcinoma.